KOD - Company ID 0001468748
The table below shows Kodiak Sciences Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$40.01M | -$29.08M | -$39.60M | -$47.22M | -$43.16M | -$34.63M |
| Capital expenditure | $942.00K | $270.00K | $22.00K | $12.17M | $17.46M | $1.24M |
| Investing cash flow | -$942.00K | -$270.00K | -$166.00K | $173.41M | -$18.29M | $9.22M |
| Dividends paid | - | - | - |
Kodiak Sciences Inc. reported operating cash flow of -$136.01M for fiscal year 2025. That is down 15.9% from -$117.32M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$16.05M (FY 2016) to -$136.01M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $619.00K | $124.00K | $38.00K | -$3.00K | $1.67M | $1.47M |